OSU-6162
外观
![]() | |
臨床資料 | |
---|---|
ATC碼 |
|
识别信息 | |
| |
CAS号 | 156907-84-5 |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.216.320 |
化学信息 | |
化学式 | C15H23NO2S |
摩尔质量 | 281.41 g·mol−1 |
3D模型(JSmol) | |
| |
|
OSU-6162,也称为PNU-96391,是一种含氮有机硫化合物,化学式C
15H
23NO
2S,结构上与普利多匹定(PL-101)类似,可作为多巴胺受體D2和5-HT2A受体的部分激动剂[1][2][3]。
参考文献
[编辑]- ^ Ekesbo A, Andrén PE, Gunne LM, Tedroff J. (-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease. NeuroReport. July 1997, 8 (11): 2567–70. PMID 9261828. S2CID 29806568. doi:10.1097/00001756-199707280-00029.
- ^ Tedroff J, Torstenson R, Hartvig P, Sonesson C, Waters N, Carlsson A, et al. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity. Synapse. April 1998, 28 (4): 280–7. PMID 9517836. S2CID 2090820. doi:10.1002/(SICI)1098-2396(199804)28:4<280::AID-SYN3>3.0.CO;2-5.
- ^ Tedroff J, Ekesbo A, Sonesson C, Waters N, Carlsson A. Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease. Neurology. October 1999, 53 (7): 1605–6. PMID 10534281. doi:10.1212/wnl.53.7.1605.